Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response

The antibody-dependent cellular cytotoxicity (ADCC) effector function of natural killer (NK) cells is one of the known mechanisms of action for rituximab-based anti-cancer immunotherapy. Inhibition of the ADCC function of NK cells through interactions between inhibitory killer cell immunoglobulin-li...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Dhon Roméo Makanga, Maxime Jullien, Gaëlle David, Nolwenn Legrand, Catherine Willem, Léa Dubreuil, Alexandre Walencik, Cyrille Touzeau, Thomas Gastinne, Benoit Tessoulin, Steven Le Gouill, Béatrice Mahé, Katia Gagne, Patrice Chevallier, Béatrice Clemenceau, Christelle Retière
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2021-01-01
Serie:	OncoImmunology
Soggetti:	kir hla adcc rituximab nk cells cd16 non hodgkin lymphoma
Accesso online:	http://dx.doi.org/10.1080/2162402X.2021.1936392
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!